Talecris Biotherapeutics

  Home About Talecris Therapeutic Areas Research & Development Donor to Patient Media Center Talecris Careers  
Media Center Overview
Press Releases
Press Releases Archive
News Features
The History of Talecris
Talecris Leadership
Talecris Media Contact Information

Press Releases

Talecris Biotherapeutics Showcases Its Clayton Facility to State and Local Dignitaries

Talecris Biotherapeutics Showcases Its Clayton Facility to State and Local Dignitaries

RESEARCH TRIANGLE PARK, N.C. (Nov. 4, 2005) – Talecris Biotherapeutics, a leading provider of plasma-based therapeutic proteins, is hosting an open house at their state-of-the-art manufacturing facility in Clayton, N.C., for state, local, and community officials. Recently recognized as one of "Five Companies to Watch" by the Triangle Business Journal, Talecris was launched in April 2005, inheriting a legacy of more than 60 years of providing lifesaving and life-enhancing plasma-derived therapeutic proteins from Bayer Biological Products' plasma division. With local roots spanning more than 30 years, Talecris is taking this opportunity to reaffirm its commitment to their employees, local community, and patients who benefit from their premium protein therapies. Talecris is a major employer in the region, employing more than 1,700 – approximately 1,400 at the Clayton facility alone. Talecris has been an active supporter and participant in the development of the Johnston County Economic Development and Training District, designed to support the local economy and workforce. In addition, Talecris supports various other local organizations in Johnston, Wake, and Durham counties.

"Through its cutting-edge technology products, Talecris Biotherapeutics is an example of how America can compete and win in the global marketplace of the 21st century," said Congressman Bob Etheridge, who represents Clayton as part of North Carolina's 2nd Congressional District. "The investment that Talecris Biotherapeutics is making in our community is helping Johnston County to be an even better place to live, work, and raise a family. Their high-quality jobs and commitment to the community bring continued opportunity to Johnston County."

Dignitaries in attendance will tour Talecris' primary manufacturing facility in Clayton – the only state-of-the-art facility in the region completely dedicated to the production of therapeutic proteins that treat rare diseases, including immune deficiencies and genetic emphysema. The open house and tour allow attendees to observe firsthand Talecris' entrepreneurial approach to new product development, application of cutting-edge manufacturing technologies, and quality customer service. With a vision to develop innovative therapies and pioneering product advances, Talecris will share exciting initiatives currently underway, as well as future development plans.

"Talecris is grateful for the opportunity to share our highly technical, scientific manufacturing and product development environment with our local community leaders," said Talecris' Senior Vice President of Operations, Mary Kuhn. "We take very seriously our obligation to be a good corporate citizen, and we are proud to share the industry-leading work we do with local dignitaries, as well as our customers and patient communities. We benefit from the exchanges that take place during our open houses and are always looking for ways to give back to the local community that supports us so strongly."

Contact:
Lacy McMahon
Tel.: 919.316.6316, Fax: 919.316.6673
E-mail: lacy.mcmahon@talecris.com

About Talecris Biotherapeutics
Talecris is a newly formed company with the assets and history of Bayer HealthCare Biological Products Division's plasma business. With global headquarters in Research Triangle Park, N.C., primary manufacturing facilities for Talecris products in Clayton, N.C., and additional fractionation and manufacturing facilities of Precision Pharma Services in Melville, N.Y., Talecris employs nearly 1700 people.

Inheriting a legacy of more than 60 years of providing lifesaving and life-enhancing plasma-derived therapeutic proteins, Talecris is well positioned to become recognized as the global leader in developing and delivering premium protein products. Through its people, technology, and state-of-the-art facilities, Talecris will build on this long history of innovation through a focused, entrepreneurial approach to new product development, application of cutting-edge manufacturing technologies, and marketing and customer service. Talecris is talented industry professionals providing critical care treatments and services for patients, while maintaining a vision for the future of care.

Information about Talecris can be found at www.talecris.com. To receive e-mail updates when new information is added to the Talecris Web site, please register at http://www.talecris.com/media_contact.cfm.

 

 

Print This Page
E-mail This Page
News & Events
See how Talecris is being recognized for innovation and commitment.
Learn More

Talecris Biotherapeutics
Contact Talecris    Glossary    Site Map
General Conditions of Use    Privacy Statement    California Compliance
© 2008 Talecris Biotherapeutics